JMP Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
Kura Oncology Analyst Ratings
H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $24
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $24
H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40
JMP Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
Strategic Advancements and Early NDA Submission Drive Buy Rating for Kura Oncology
Kura Oncology Price Target Cut to $14.00/Share From $27.00 by UBS
Kura Oncology Analyst Ratings
UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Cuts Target Price to $14
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)
JMP Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $10 to $40
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $24 to $40
Kura Oncology Price Target Maintained With a $40.00/Share by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Kura Oncology (KURA) and CareDx (CDNA)
Kura Oncology Analyst Ratings
Leerink Partners Maintains Kura Oncology(KURA.US) With Buy Rating, Announces Target Price $23
Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)